1年目の Bronchopulmonary Dysplasia: 重症度,薬剤使用,および医療利用に関する洞察
Eliaz Brumer1,2, Veronika Shabanova2,3, Haley Urbach2
1Department of Pediatrics, Section of Pulmonary, Allergy-Immunology, and Sleep Medicine, Yale University, New Haven, Connecticut, USA.
Pediatric pulmonology
|August 26, 2025
まとめ
Bronchopulmonary dysplasia (BPD) を発症した乳児は,発症後の呼吸器系に重大な問題があり,発症後の医療の必要性が増加します. 構造的なフォローアップは,重症度に関係なく,すべてのBPD患者にとって呼吸器疾患の管理に不可欠です.
科学分野:
- 新生児医学
- 小児肺科
- 呼吸器医学
背景:
- Bronchopulmonary dysplasia (BPD) は,早産児における流行している慢性肺疾患である.
- BPDの重症度が 呼吸器疾患と医療の利用に与える影響を理解することは 医療の最適化に不可欠です
- デキサメタゾンのようなNICU介入とNICU後のフォローアップの役割は,さらなる特徴づけを必要としています.
研究 の 目的:
- BPDの重症度とNICU後の呼吸器のアウトカムと医療利用の関連性を調べる.
- 呼吸器疾患に対する外来小児肺疾患フォローアップの影響を評価する.
- 乳児集中治療室でのデキサメタゾンの投与が退院後の呼吸器の健康に与える影響を評価する.
主な方法:
- 2019年の重症度分類を用いて,BPDと診断された161人の乳児 (2021年−2023年) の遡及的なコホート研究.
- 評価された主なアウトカム:薬の処方 (アルブテロール,吸入/全身ステロイド),ED訪問,NICU退院後1年以内に入院.
- デキサメタゾンの使用,肺学的フォローアップ,呼吸器疾患関連性の分析
主要な成果:
- BPDの重度の分布: 32. 9% グレード-1, 59. 0% グレード-2, 8. 1% グレード-3.
- デキサメタゾンの使用と肺疾患のフォローアップ率は,BPDの重症度 (p<0. 001) により増加した.
- ほぼ半分 (47. 2%) が退院後,呼吸器科の病院訪問を経験し,22. 3% が入院した.
結論:
- BPDの乳児における呼吸器疾患率と医療利用率は,疾患の重症度によって増加する.
- 呼吸器科の病院訪問は,軽度の症例も含め,全重度のBPDにおいて大きな負担となっています.
- 呼吸器疾患の罹患率を軽減するために,構造化された縦断的な追跡はすべての乳児にとって不可欠です.
関連する概念動画
Inhaled Medications
388
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
388
Pulmonary Cycle: Exhalation
1.8K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.8K
COPD: Management Using Bronchodilators and Corticosteroids
307
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
307
Drugs Used in Lower Respiratory Disorders: Overview
578
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
578
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K


